Nuvation Bio Q2 Earnings Call Highlights
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Sat, 8 August 2026
What it is about
Who published it, and when
How it spread - 1 original report
Sat, 8 August 2026
1 report- dailypolitical.com14:04first to report
Nuvation Bio (NYSE:NUVB) reported second-quarter total revenue of $31.7 million, including $23.2 million in net U.S. product revenue from IBTROZI, as the company said use of the ROS1-targeted lung cancer therapy continued to shift toward first-line patients. IBTROZI revenue increased 25% from the first quarter, while approximately 160 patients began treatment during the period, Chief […]